These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35943399)

  • 21. Treatment of Cannabinoid Hyperemesis With Olanzapine: A Case Series.
    Hsu J; Herrmann Z; Kashyap S; Claassen C
    J Psychiatr Pract; 2021 Jul; 27(4):316-321. PubMed ID: 34398582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cannabinoid-induced hyperemesis].
    Lieb M; Palm U; Nicolaus M; Reibke R; Baghai TC
    Psychiatr Prax; 2011 Apr; 38(3):147-9. PubMed ID: 21462097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoid Hyperemesis Syndrome and the Consulting Psychiatrist: A Case Study of Diagnosis and Treatment for an Emerging Disorder in Psychiatric Practice.
    Kast KA; Gershengoren L
    J Psychiatr Pract; 2018 Jan; 24(1):51-55. PubMed ID: 29320384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome.
    Lee C; Greene SL; Wong A
    Clin Toxicol (Phila); 2019 Sep; 57(9):773-777. PubMed ID: 30729854
    [No Abstract]   [Full Text] [Related]  

  • 25. Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse.
    Sontineni SP; Chaudhary S; Sontineni V; Lanspa SJ
    World J Gastroenterol; 2009 Mar; 15(10):1264-6. PubMed ID: 19291829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.
    Venkatesan T; Levinthal DJ; Li BUK; Tarbell SE; Adams KA; Issenman RM; Sarosiek I; Jaradeh SS; Sharaf RN; Sultan S; Stave CD; Monte AA; Hasler WL
    Neurogastroenterol Motil; 2019 Jun; 31 Suppl 2(Suppl 2):e13606. PubMed ID: 31241817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid hyperemesis syndrome: an underreported entity causing nausea and vomiting of pregnancy.
    Schmid SM; Lapaire O; Huang DJ; Jürgens FE; Güth U
    Arch Gynecol Obstet; 2011 Nov; 284(5):1095-7. PubMed ID: 21170540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabis-Related Cyclic/Episodic Hyperemesis Conditions: From Suspected to Definitive Cannabinoid Hyperemesis Syndrome.
    Bonnet U
    Med Princ Pract; 2022; 31(5):497-498. PubMed ID: 35817019
    [No Abstract]   [Full Text] [Related]  

  • 29. Cannabinoid Hyperemesis Syndrome in Pediatrics: An Emerging Problem.
    Dosani K; Koletic C; Alhosh R
    Pediatr Rev; 2021 Sep; 42(9):500-506. PubMed ID: 34470869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid hyperemesis syndrome.
    Galli JA; Sawaya RA; Friedenberg FK
    Curr Drug Abuse Rev; 2011 Dec; 4(4):241-9. PubMed ID: 22150623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocannabinoid system and cannabis hyperemesis syndrome: a narrative update.
    Perisetti A; Goyal H
    Eur J Gastroenterol Hepatol; 2022 Jan; 34(1):1-8. PubMed ID: 33208685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States.
    Soriano-Co M; Batke M; Cappell MS
    Dig Dis Sci; 2010 Nov; 55(11):3113-9. PubMed ID: 20130993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoid hyperemesis syndrome: a cause of refractory nausea and vomiting in pregnancy.
    Alaniz VI; Liss J; Metz TD; Stickrath E
    Obstet Gynecol; 2015 Jun; 125(6):1484-1486. PubMed ID: 25774930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addressing cannabis consumption among patients with hyperemesis gravidarum.
    Galvin SL; Coulson CC
    AJOG Glob Rep; 2023 May; 3(2):100180. PubMed ID: 36911236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid Hyperemesis Syndrome: A Review of the Presentation and Treatment.
    Leu N; Routsolias JC
    J Emerg Nurs; 2021 May; 47(3):483-486. PubMed ID: 33712244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of gabapentin on hyperemesis gravidarum: a double-blind, randomized controlled trial.
    Guttuso T; Messing S; Tu X; Mullin P; Shepherd R; Strittmatter C; Saha S; Thornburg LL
    Am J Obstet Gynecol MFM; 2021 Jan; 3(1):100273. PubMed ID: 33451591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline.
    Lapoint J; Meyer S; Yu CK; Koenig KL; Lev R; Thihalolipavan S; Staats K; Kahn CA
    West J Emerg Med; 2018 Mar; 19(2):380-386. PubMed ID: 29560069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Spontaneuos pneumomediastinum secondary to cannabinoid hyperemesis syndrome].
    Hernández-Ramos I; Parra-Esquivel P; López-Hernández Á; Burillo-Putze G
    An Sist Sanit Navar; 2019 Aug; 42(2):227-230. PubMed ID: 31133765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoid hyperemesis syndrome: a guide for the practising clinician.
    Bajgoric S; Samra K; Chandrapalan S; Gautam N
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26698198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid Hyperemesis Syndrome: An Emerging Drug-Induced Disease.
    Woods JA; Wright NJ; Gee J; Scobey MW
    Am J Ther; 2016; 23(2):e601-5. PubMed ID: 24413371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.